Media Room
Fourth Quarter and Full Year 2024 Results
Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.
Thursday January 30, 2025
15:00 - 16:30 CET (9:00am – 10:30am EST)
Press releases
March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue
February 28, 2025
Media Update: AAD: new data advance Sanofi’s scientific leadership across innovative treatments for inflammatory skin diseases
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
Registration Document 2024 (in French)
XBRL Viewer 20F 2024